{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-fdaaa-801-registration-results-posting-prs-compliance”
},
“headline”: “SOP for FDAAA 801 Registration/Results Posting (PRS Compliance)”,
“description”: “This SOP defines procedures for registering clinical trials and posting results on ClinicalTrials.gov to ensure compliance with FDAAA 801 and PRS requirements. It covers timelines, sponsor responsibilities, CRO oversight, quality control, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for FDAAA 801 Registration/Results Posting (PRS Compliance)

Purpose

The purpose of this SOP is to establish procedures for registering clinical trials and posting results on ClinicalTrials.gov in compliance with the FDA Amendments Act (FDAAA) Section 801 and Protocol Registration and Results System (PRS). It ensures adherence to regulatory timelines and transparency obligations.

Scope

This SOP applies to sponsors, investigators, CROs, regulatory affairs teams, and data managers responsible for ClinicalTrials.gov submissions. It covers registration before trial initiation, updates during the trial, results posting upon completion, and handling of FDA inspections.

Responsibilities

• Sponsor: Ensures all applicable trials are registered and results are submitted within timelines.
• Investigator: Provides accurate study information and ensures data integrity.
• Regulatory Affairs: Prepares, reviews, and submits PRS entries to ClinicalTrials.gov.
• CRO: Supports PRS compliance activities and conducts quality reviews.
• QA: Audits PRS processes and ensures inspection readiness.

Accountability

The Sponsor’s Regulatory Affairs Lead is accountable for compliance with FDAAA 801 PRS requirements. Investigators are accountable for providing complete and accurate study data.

Procedure

1. Trial Registration
1.1 Register applicable clinical trials on ClinicalTrials.gov within 21 days of first subject enrollment.
1.2 Record in PRS Registration Log (Annexure-1).

2. Updates During the Trial
2.1 Update trial information within 30 days of protocol amendments or recruitment status changes.
2.2 Maintain updates in PRS Amendment Log (Annexure-2).

3. Results Posting
3.1 Submit summary results within 12 months of primary completion date.
3.2 Include baseline data, outcomes, adverse events, and protocol.
3.3 Record in PRS Results Posting Log (Annexure-3).

4. Quality Control
4.1 Perform internal QC checks before PRS submission.
4.2 Address ClinicalTrials.gov QC comments within 25 days.
4.3 Record in PRS QC Log (Annexure-4).

5. Compliance Monitoring
5.1 Maintain tracking of registration and results timelines.
5.2 Document compliance in PRS Compliance Log (Annexure-5).

6. Inspection Readiness
6.1 Ensure PRS records are inspection-ready.
6.2 Conduct mock inspections documented in PRS Inspection Readiness Log (Annexure-6).

Abbreviations

• SOP: Standard Operating Procedure
• PRS: Protocol Registration and Results System
• FDA: Food and Drug Administration
• FDAAA: Food and Drug Administration Amendments Act
• CRO: Contract Research Organization
• QA: Quality Assurance
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. PRS Registration Log (Annexure-1)
2. PRS Amendment Log (Annexure-2)
3. PRS Results Posting Log (Annexure-3)
4. PRS QC Log (Annexure-4)
5. PRS Compliance Log (Annexure-5)
6. PRS Inspection Readiness Log (Annexure-6)

References

• ClinicalTrials.gov PRS User Guide
• FDA – FDAAA 801 Requirements
• 42 CFR Part 11 – Clinical Trials Registration and Results Submission
• ICH GCP – Transparency and Disclosure Standards

Version: 1.0

Approval Section

Annexures

Annexure-1: PRS Registration Log

Annexure-2: PRS Amendment Log

Annexure-3: PRS Results Posting Log

Annexure-4: PRS QC Log

Annexure-5: PRS Compliance Log

Annexure-6: PRS Inspection Readiness Log

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-public-trial-registration-results-posting”
},
“headline”: “SOP for Public Trial Registration and Results Posting (ClinicalTrials.gov/EU/WHO)”,
“description”: “This SOP describes the procedures for registering clinical trials and posting results in public registries including ClinicalTrials.gov, EU CTR/CTIS, and WHO ICTRP. It ensures compliance with FDAAA 801, EMA, WHO, CDSCO, and ICH GCP requirements for trial transparency.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Public Trial Registration and Results Posting (ClinicalTrials.gov/EU/WHO)

Purpose

The purpose of this SOP is to outline procedures for registering clinical trials and posting results in publicly accessible registries such as ClinicalTrials.gov, EU CTR/CTIS, and WHO ICTRP. This ensures regulatory compliance, promotes transparency, and supports global commitments to public disclosure of trial information.

Scope

This SOP applies to sponsors, CROs, regulatory affairs, and clinical operations staff responsible for registering clinical trials and posting results globally. It covers initial registration, updates, result posting, quality control, and compliance monitoring.

Responsibilities

• Sponsor: Ensures trial registration and result posting is performed within required timelines.
• Regulatory Affairs: Prepares, submits, and maintains trial information in registries.
• CROs: Support sponsor in registry submissions and ensure accuracy of data.
• QA: Audits registry submissions and verifies compliance with disclosure obligations.
• Data Management: Provides final datasets and results for posting.

Accountability

The Sponsor’s Regulatory Affairs Head is accountable for ensuring that trial registration and results posting are completed accurately and within global regulatory timelines.

Procedure

1. Initial Trial Registration
1.1 Register clinical trial prior to first subject enrollment.
1.2 Use ClinicalTrials.gov, EU CTR/CTIS, and WHO ICTRP depending on region and scope.
1.3 Maintain Registry Submission Log (Annexure-1).

2. Registry Updates
2.1 Update records within 30 days of protocol amendments or changes in status.
2.2 Document changes in Registry Update Log (Annexure-2).

3. Results Posting
3.1 Post results within 12 months of primary completion date (unless otherwise defined by regulations).
3.2 Include safety, efficacy, and statistical outcomes as per registry requirements.
3.3 Document in Results Posting Log (Annexure-3).

4. Quality Control
4.1 Regulatory Affairs performs QC review of all submissions.
4.2 Address queries or rejections from registry administrators promptly.

5. Disclosure Oversight
5.1 Establish oversight process for monitoring registry compliance.
5.2 Include disclosure status in Sponsor Oversight Report (Annexure-4).

6. Archiving
6.1 Archive registry submission records, approvals, and confirmations in TMF.
6.2 Retain per global regulatory timelines.

Abbreviations

• SOP: Standard Operating Procedure
• QA: Quality Assurance
• CRO: Contract Research Organization
• TMF: Trial Master File
• EU CTR: European Union Clinical Trials Regulation
• CTIS: Clinical Trials Information System
• ICTRP: International Clinical Trials Registry Platform
• CSR: Clinical Study Report

Documents

1. Registry Submission Log (Annexure-1)
2. Registry Update Log (Annexure-2)
3. Results Posting Log (Annexure-3)
4. Sponsor Oversight Report (Annexure-4)

References

• ClinicalTrials.gov – Registration and Results Posting
• EU CTR/CTIS – Transparency Rules
• WHO ICTRP – Trial Registration Standards
• FDAAA 801 Requirements
• CDSCO – Indian Clinical Trial Registry (CTRI)

Version: 1.0

Approval Section

Annexures

Annexure-1: Registry Submission Log

Annexure-2: Registry Update Log

Annexure-3: Results Posting Log

Annexure-4: Sponsor Oversight Report

Revision History

For more SOPs visit: Pharma SOP